A new coronavirus test can help doctors quickly diagnose people who are infected with the deadly coronaviruses, the Centers for Disease Control and Prevention announced Wednesday.
The test, developed by the National Institutes of Health (NIH), can identify people who have had exposure to coronaviral-containing aerosols such as aerosols from aerosols at airports and other public places and in public places.
The coronaviroscopic test can be performed at a local laboratory and at a national lab, with the results sent to the CDC.
The new test, known as the COVID Rapid Test, uses a rapid, noninvasive process to determine if a person is infected with coronavillae.
“The new COVID test is the most accurate and reliable test to identify if a patient has COVID and can confirm if they are at high risk of infection,” said Dr. Andrew Kolodny, director of the NIH’s National Center for Immunization and Respiratory Diseases.
Since the coronavovirus was first detected in humans in December, there have been hundreds of confirmed cases of COVID.
About 4,000 people have been diagnosed with the virus, which is highly contagious.
The new coronovirus test, called the COVS-3C, uses rapid, automated testing to determine the presence of coronavacilli.
It has been used to detect coronavids in people who were at high-risk for developing COVID, but it was not widely available before the pandemic.
The COVS3C test can also be used to diagnose people with COVI, which includes COVID but also COVIDD, COVIDE, COVIS-2 and COVID19.
The test is not meant to diagnose COVID or to determine whether a person has contracted COVID in the past.
“The rapid test is one of the best diagnostic tests for COVID,” Dr. Eric Shorrock, the director of public health at Johns Hopkins University, said in a statement.
“It provides the best test for determining if you are infected and can detect COVID even before symptoms emerge.
This test is a very important tool for those who have not yet been tested.”
The test is available for free to the public through the CDC website and through an online trial.
The new test is also available at public hospitals.
The CDC recommends people who test positive for COVS take precautions such as wearing a face mask and using hand sanitizer at all times.
If symptoms begin to appear, people who tested positive for the virus should see a doctor immediately.
The National Institutes for Health (NIA) is the nation’s primary research agency and is the principal federal agency responsible for coordinating the development, research and delivery of national biomedical research and education.
For more information about the National Institute of Allergy and Infectious Diseases, please visit the NIA home page at www.nia.nih.gov.